Smart Transmucosal Devices Tailor Treatment, Shaping the US$ 62.8 Billion Market by 2030, RationalStat Predicts

The global transmucosal drug delivery devices market is expected to reach US$ 62.8 billion by 2030, with an annual growth rate of more than 6.2%.

According to RationalStat's most recent industry analysis, the Global Transmucosal Drug Delivery Devices Market value is estimated at US$ 41.2 billion in 2023 and is expected to rise at a strong CAGR of over 6.2% over the forecast period of 2023-2030.

Market Definition, Market Scope, and Report Overview

Transmucosal drug delivery devices refer to medical devices designed to administer drugs through mucous membranes, bypassing the digestive system and allowing for direct absorption into the bloodstream. These devices are used to deliver medications through various mucosal surfaces, such as the oral mucosa, nasal mucosa, buccal (cheek) mucosa, and rectal mucosa.
The market is driven by the development and adoption of transmucosal drug delivery devices for emerging therapeutic areas, such as immunotherapy, precision medicine, and personalized medicine.

According to a deep-dive market assessment by RationalStat, the global transmucosal drug delivery devices market has been analyzed on the basis of market segments, including type, route of administration, application, end user, and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.

• Market intelligence for the global transmucosal drug delivery devices market covers market sizes on the basis of market value (US$/EUR Million), volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.

• In addition, the long-term sector and products/services 10-year outlook and its implications on the global transmucosal drug delivery devices market. It also includes the industry's current state - Production levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.

Request A Customization- https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/#tab-ux_global_tab

Global Transmucosal Drug Delivery Devices Market: Segmental and Market Share Analysis

• On the basis of route of administration, nasal sprays are mostly preferred by patients as they are easy to use and will absorb rapidly This segment will show its dominance during the forecast period.

Report Synopsis
Report Metrics Details
Base Year 2023
Forecast Period 2023-2030
Base Year Market Size US$ 41.2 billion
Market Size Forecast US$ 62.8 billion
Growth Rate 6.2%
Dominant Segment Nasal Sprays
Dominant Region North America
Key Market Drivers • Prevalence of chronic disorder
• Use of therapeutic pharmaceuticals
Companies Profiled • Abbott
• Bayer AG
• Teva Pharmaceuticals
• Slan Medicinal Holdings Ltd
• MMB Healthcare Services Ltd
• Laso Biodelivery
• Mylan
• Novartis
• Bristol-Myers Squibb Pharma Company
• Johnson & Johnson
• Antares Pharma Inc.
• BD
• 3M
• Pfizer
• Boehringer Ingelheim GmbH
• Endo International plc
• Echo Pharmaceuticals
• B. Braun Melsungen Aktiengesellschaft
• Baxter Pharmaceuticals
• GSK
• Acrux

Explore more about this report- https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/#tab-ux_global_tab

Competition Analysis and Market Structure
Some leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & and acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players.
• In January 2021, Novartis AG acquired Credence MedSystems to assist in the development and scaling-up of its drug delivery systems. As a result of this initiative, Novartis AG will be able to apply the Credence technology in its injectable medicines.

Some of the prominent players and suppliers operating and contributing significantly to the global transmucosal drug delivery devices market growth include Abbott, Bayer AG, Teva Pharmaceuticals, Slan Medicinal Holdings Ltd, MMB Healthcare Services Ltd, Laso Biodelivery, Mylan, Novartis, Bristol-Myers Squibb Pharma Company, Johnson & Johnson, Antares Pharma Inc., BD, 3M, Pfizer, Boehringer Ingelheim GmbH, Endo International plc, Echo Pharmaceuticals, B. Braun Melsungen Aktiengesellschaft, Baxter Pharmaceuticals, GSK, and Acrux, among others.

Get A Free Sample- https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/#tab-ux_global_tab

RationalStat has segmented the global transmucosal drug delivery devices market based on type, route of administration, application, end user and region
• Global Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Type
o Passive Transdermal Drug Delivery
o Active Transdermal Drug Delivery
• Global Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Route of administration
o Nasal Spray
 Metered Dose Nasal Sprays
 Nasal Powder Sprays
o Buccal
 Buccal Tablets
 Buccal Films
o Sublingual
 Sublingual Tablets
 Sublingual Films
o Inhalation
 Dry Powder Inhalers (DPIs)
 Metered Dose Inhalers (MDIs)
 Nebulizers
o Vaginal
 Vaginal Rings
 Vaginal Gels
o Rectal
 Suppositories
 Enemas

• Global Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Application
o Pain Management
o Cardiovascular Disorders
o Neurological Disorders
o Hormonal Disorders
o Others (Cancer Pain Management, Infectious Diseases, Gastrointestinal Disorders)
• Global Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by End User
o Hospitals and Clinics
o Home Care
o Ambulatory Surgical Centers
o Research and Academic Institutes
• Global Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Region
o North America Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 US
 Canada
o Latin America Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 Brazil
 Mexico
 Rest of Latin America
o Western Europe Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 Germany
 UK
 France
 Spain
 Italy
 Benelux
 Nordic
 Rest of Western Europe
o Eastern Europe Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 Russia
 Poland
 Hungary
 Other CIS Countries
 Rest of Eastern Europe
o Asia Pacific Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 China
 Japan
 India
 South Korea
 Australia
 ASEAN
• Indonesia
• Thailand
• Philippines
• Vietnam
• Malaysia
• Rest of ASEAN
 Rest of Asia Pacific
o Middle East & Africa Transmucosal Drug Delivery Devices Market Value (US$ Million), Volume (Units) and Market Share (2019-2030) Analysis by Country
 GCC
• Saudi Arabia (KSA)
• United Arab Emirates (UAE)
• Rest of the GCC
 South Africa
 Nigeria
 Turkey
 Rest of the Middle East & Africa

For more information about this report- https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/

Key Questions Answered in the Transmucosal Drug Delivery Devices Report:
• What will be the market value of the global Transmucosal Drug Delivery Devices market by 2030?
• What is the market size of the global Transmucosal Drug Delivery Devices market?
• What are the market drivers of the global Transmucosal Drug Delivery Devices market?
• What are the key trends in the global Transmucosal Drug Delivery Devices market?
• Which is the leading region in the global Transmucosal Drug Delivery Devices market?
• What are the major companies operating in the global Transmucosal Drug Delivery Devices market?
• What are the market shares by key segments in the global Transmucosal Drug Delivery Devices market?

Running a year End discount of 20%
https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/#tab-ux_global_tab

Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts' viewpoint to create a research methodology for market sizing and forecasting.

RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
• Defining the problem by understanding the type of market and data required by the client.
• Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
• Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
• Evaluating and analyzing the data by referring to data sources utilized and leveraged.
• Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.

Download Key Insights and Market Data - Raise a Query
https://store.rationalstat.com/store/global-transmucosal-drug-delivery-devices-market/#tab-ux_global_tab

RationalStat LLC
Kimberly Shaw,
Content and Press Manager
sales@rationalstat.com
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest

RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.

This release was published on openPR.